Project Grant R01HL172844
Award Date
1/15/25
Completion Date
11/30/28
Dollars Obligated
$504K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Kentucky, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Federal Grant Program CFDA 93.837 - Cardiovascular Diseases Research, provides $391,250.00 to Emory University to investigate fibrinogen as a pathologic and targetable mediator of COVID-19-associated coagulopathy. The key objectives are to: 1) Define the impact of therapeutic plasma exchange (TPE) on blood rheology and vascular integrity in COVID-19 patients by analyzing plasma samples before and after...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $151,523 to The Medical College of Wisconsin, Inc. to investigate the role of fibrinogen in regulating inflammation and thrombus resolution in acute and chronic venous thrombosis. The research aims to develop a novel RNA therapy using lipid nanoparticles to selectively reduce circulating fibrinogen levels and elucidate its impact on thromboinflammatory processes....
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $2,232,348 to Indiana University Indianapolis to study the immunologic mechanisms underlying chronic lung disease in patients after acute COVID-19 infection. The study aims to: 1) Obtain bronchoalveolar lavage (BAL) and blood samples from patients with post-COVID lung disease to conduct mechanistic studies, including follow-up bronchoscopies; 2) Further...
This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,340,904 to researchers at the University of Virginia and University of Manchester to study the role of interleukin-13 (IL-13) and hyaluronan in the pathology of COVID-19. The key objectives are to: 1) Determine how IL-13 is induced and impacts hyaluronan matrix formation and lung inflammation in a mouse model of SARS-CoV-2 infection, 2) Investigate the...
This Project Grant awarded by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research into the role of low-density lipoprotein (LDL) in hemostasis and its potential impact on hemophilia A, a hereditary bleeding disorder. The primary objectives are to: 1) Test the hypothesis that LDL associates with Factor VIII-von Willebrand Factor and improves hemostasis; 2) Evaluate if LDL extends Factor VIII half-life with slower clearance; and 3)...
This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $601,677 to the University of Massachusetts to conduct multi-scale research on the mechanisms underlying a rare but dangerous immunothrombotic side effect, known as vaccine-induced immune thrombotic thrombocytopenia (VITT), associated with adenoviral-vectored vaccines. The research aims to elucidate the molecular and biochemical triggers of VITT...
This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,332,404 to The Medical College of Wisconsin, Inc. to investigate the role of basolateral endothelial cilia in promoting vascular stability in the brain. The research aims to evaluate the localization of platelet-derived growth factor-BB (PDGF-BB) in the context of the extracellular matrix and basolateral endothelial cilia, investigate the role of...
This federal Project Grant award of $1,127,798 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to understand the role of macrophages in preserving cardiovascular health and their contributions to cardiovascular disease (CVD). The overarching goal is to identify new therapeutic targets for CVD in both female and male patients. The research will use advanced single cell imaging and omics techniques to characterize harmful...
This is a Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research (CFDA 93.837) program. The $827,682 award will fund a comprehensive research project to develop advanced imaging techniques, including dynamic contrast-enhanced CT, dual-energy CT, and electrical impedance tomography, to characterize pulmonary perfusion and guide personalized treatment of acute respiratory distress...
This Project Grant award of $1,276,908 from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research, will support advanced research by Bloodworks, a non-profit organization based in Seattle, Washington. The research aims to increase understanding of the mechanisms of disease in von Willebrand disease and sickle cell disease, which both involve the von Willebrand factor. Key focus areas include investigating the impact of VWF cleavage fragments...